The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Non–T Cell Activation Linker (NTAL)
Open accessAbstract
A key molecule necessary for activation of T lymphocytes through their antigen-specific T cell receptor (TCR) is the transmembrane adaptor protein LAT (linker for activation of T cells). Upon TCR engagement, LAT becomes rapidly tyrosine phosphorylated and then serves as a scaffold organizing a multicomponent complex that is indispensable for induction of further downstream steps of the signaling cascade. Here we describe the identification and preliminary characterization of a novel transmembrane adaptor protein that is structurally and evolutionarily related to LAT and is expressed in B lymphocytes, natural killer (NK) cells, monocytes, and mast cells but not in resting T lymphocytes. This novel transmembrane adaptor protein, termed NTAL (non–T cell activation linker) is the product of a previously identified WBSCR5 gene of so far unknown function. NTAL becomes rapidly tyrosine-phosphorylated upon cross-linking of the B cell receptor (BCR) or of high-affinity Fcγ- and Fcε-receptors of myeloid cells and then associates with the cytoplasmic signaling molecules Grb2, Sos1, Gab1, and c-Cbl. NTAL expressed in the LAT-deficient T cell line J.CaM2.5 becomes tyrosine phosphorylated and rescues activation of Erk1/2 and minimal transient elevation of cytoplasmic calcium level upon TCR/CD3 cross-linking. Thus, NTAL appears to be a structural and possibly also functional homologue of LAT in non–T cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wienands, J., Schweikert, J., Wollscheid, B., Jumaa, H., Nielsen, P. J., & Reth, M. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.4.791 · Cited by 271
Self-citationIshiai, M., Sugawara, H., Kurosaki, M., & Kurosaki, T. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.4.1746 · Cited by 71
Cited by
Integrated signalling pathways for mast-cell activation
Gilfillan, A. M., & Tkaczyk, C. (2006) · Nature Reviews Immunology · doi:10.1038/nri1782 · Cited by 950
New developments in FcεRI regulation, function and inhibition
Kraft, S., & Kinet, J.-P. (2007) · Nature Reviews Immunology · doi:10.1038/nri2072 · Cited by 579
GPVI and integrin αIIbβ3 signaling in platelets
WATSON, S. P., AUGER, J. M., McCARTY, O. J. T., & PEARCE, A. C. (2005) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2005.01429.x · Cited by 430
Palmitoylation of Ligands, Receptors, and Intracellular Signaling Molecules
Resh, M. D. (2006) · Science's STKE · doi:10.1126/stke.3592006re14 · Cited by 414
Mast cell signal transduction from the high-affinity IgE receptor
Siraganian, R. P. (2003) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.09.010 · Cited by 286
Metadata
- Authors
- Brdička, T., Imrich, M., Angelisová, P., Brdičková, N., Horváth, O., Špička, J., Hilgert, I., Lusková, P., Dráber, P., Novák, P., Engels, N., Wienands, J., Simeoni, L., Österreicher, J., Aguado, E., Malissen, M., Schraven, B., & Hořejší, V.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2002-12-16
- Volume
- 196
- Issue
- 12
- Pages
- 1617-1626
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2129108588
- Cited by
- 199
- References
- 2
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Non–T Cell Activation Linker (NTAL). https://app.cochat.ai/papers/10.1084/jem.20021405
- The paper
- Brdička, T., Imrich, M., Angelisová, P., Brdičková, N., Horváth, O., Špička, J., Hilgert, I., Lusková, P., Dráber, P., Novák, P., Engels, N., Wienands, J., Simeoni, L., Österreicher, J., Aguado, E., Malissen, M., Schraven, B., & Hořejší, V. (2002). Non–T Cell Activation Linker (NTAL). The Journal of Experimental Medicine. https://doi.org/10.1084/jem.20021405
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.